AARTIDRUGS — Aarti Drugs Cashflow Statement
0.000.00%
- IN₹42.33bn
- IN₹48.25bn
- IN₹23.87bn
- 83
- 27
- 54
- 57
Annual cashflow statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3,690 | 2,700 | 2,242 | 2,355 | 2,118 |
Depreciation | |||||
Non-Cash Items | 187 | 204 | 348 | 316 | 286 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,827 | -2,707 | -1,760 | 404 | -515 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,550 | 696 | 1,333 | 3,589 | 2,446 |
Capital Expenditures | -882 | -1,520 | -1,648 | -2,263 | -1,772 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 165 | 31.1 | 8.46 | 26.8 | 125 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -718 | -1,489 | -1,640 | -2,237 | -1,646 |
Financing Cash Flow Items | -230 | -344 | -362 | -446 | -468 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -811 | 920 | 165 | -1,360 | -821 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 20.4 | 128 | -141 | -7.61 | -21.7 |